Immediate Impact
4 from Science/Nature 55 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Works of Daniel Kelly being referenced
Testosterone and insulin resistance in the metabolic syndrome and T2DM in men
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniel Kelly | 632 | 213 | 84 | 189 | 16 | 1.0k | |
| Steven M. Haffner | 604 | 134 | 42 | 131 | 16 | 1.1k | |
| Karine Blouin | 478 | 136 | 46 | 177 | 28 | 1000 | |
| Manav Batra | 712 | 229 | 32 | 203 | 31 | 1.0k | |
| Nitesh Kuhadiya | 733 | 197 | 25 | 203 | 26 | 1.0k | |
| Antoine Makdissi | 996 | 238 | 25 | 261 | 31 | 1.3k | |
| Mark Ng Tang Fui | 685 | 304 | 40 | 215 | 23 | 1.1k | |
| Marcia F. Kalin | 564 | 108 | 39 | 174 | 16 | 1.3k | |
| Norman H. Ertel | 448 | 97 | 35 | 290 | 34 | 1.3k | |
| Jee‐Young Oh | 550 | 185 | 25 | 111 | 16 | 952 | |
| Michael J. Diver | 728 | 198 | 121 | 203 | 17 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...